20 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alpha-biopharma-received-nmpa-approval-for-zorifertinib-tablets-zorifer-the-worlds-first-egfr-tki-for-lung-cancer-with-brain-metastases-302311486.html
29 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alpha-biopharma-submits-new-drug-application-for-zorifertinib-a-next-generation-egfr-tki-to-treat-egfr-mutated-nsclc-patients-with-cns-metastases-301733086.html